
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
IL-10 in cancer: Just a classical immunosuppressive factor or also an immunostimulating one?
Fernanda Costa Brandão Berti, Karen Brajão de Oliveira
AIMS Allergy and Immunology (2018) Vol. 2, Iss. 2, pp. 88-97
Open Access | Times Cited: 24
Fernanda Costa Brandão Berti, Karen Brajão de Oliveira
AIMS Allergy and Immunology (2018) Vol. 2, Iss. 2, pp. 88-97
Open Access | Times Cited: 24
Showing 24 citing articles:
Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-10
Kathrine S Rallis, Amber Elyse Corrigan, Hashim Dadah, et al.
Anticancer Research (2021) Vol. 41, Iss. 7, pp. 3247-3252
Open Access | Times Cited: 67
Kathrine S Rallis, Amber Elyse Corrigan, Hashim Dadah, et al.
Anticancer Research (2021) Vol. 41, Iss. 7, pp. 3247-3252
Open Access | Times Cited: 67
NK cell exhaustion in the tumor microenvironment
Jia Hao, Hongmei Yang, Huaxing Xiong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 34
Jia Hao, Hongmei Yang, Huaxing Xiong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 34
Insights in the immunobiology of glioblastoma
Dimitrios Strepkos, Mariam Markouli, Αλεξία Κλώνου, et al.
Journal of Molecular Medicine (2019) Vol. 98, Iss. 1, pp. 1-10
Closed Access | Times Cited: 60
Dimitrios Strepkos, Mariam Markouli, Αλεξία Κλώνου, et al.
Journal of Molecular Medicine (2019) Vol. 98, Iss. 1, pp. 1-10
Closed Access | Times Cited: 60
IL-10 in cancer: an essential thermostatic regulator between homeostatic immunity and inflammation – a comprehensive review
Kathrine S Rallis, Amber Elyse Corrigan, Hashim Dadah, et al.
Future Oncology (2022) Vol. 18, Iss. 29, pp. 3349-3365
Closed Access | Times Cited: 18
Kathrine S Rallis, Amber Elyse Corrigan, Hashim Dadah, et al.
Future Oncology (2022) Vol. 18, Iss. 29, pp. 3349-3365
Closed Access | Times Cited: 18
Combination of ovalbumin-coated iron oxide nanoparticles and poly(amidoamine) dendrimer-cisplatin nanocomplex for enhanced anticancer efficacy
Tefera Worku Mekonnen, Haile Fentahun Darge, Hsieh‐Chih Tsai, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 213, pp. 112391-112391
Closed Access | Times Cited: 16
Tefera Worku Mekonnen, Haile Fentahun Darge, Hsieh‐Chih Tsai, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 213, pp. 112391-112391
Closed Access | Times Cited: 16
Exploring the Link between Inflammatory Biomarkers and Head and Neck Cancer: Understanding the Impact of Smoking as a Cancer-Predisposing Factor
Jarosław Nuszkiewicz, Joanna Wróblewska, Marlena Budek, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 748-748
Open Access | Times Cited: 2
Jarosław Nuszkiewicz, Joanna Wróblewska, Marlena Budek, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 748-748
Open Access | Times Cited: 2
Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model
Hyun‐Ah Kim, Hyun‐Soo Kim, Min‐Kyung Nam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Hyun‐Ah Kim, Hyun‐Soo Kim, Min‐Kyung Nam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Role of regulatory B cells in gastric cancer: Latest evidence and therapeutics strategies
Yuanming Jing, Fangming Xu, Wenqing Liang, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107581-107581
Closed Access | Times Cited: 14
Yuanming Jing, Fangming Xu, Wenqing Liang, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107581-107581
Closed Access | Times Cited: 14
The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia
Laura Jimbu, Oana Mesaros, Alexandra Neaga, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1105-1105
Open Access | Times Cited: 14
Laura Jimbu, Oana Mesaros, Alexandra Neaga, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1105-1105
Open Access | Times Cited: 14
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment
Marco Merlano, Matteo Paccagnella, Nerina Denaro, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5257-5257
Open Access | Times Cited: 4
Marco Merlano, Matteo Paccagnella, Nerina Denaro, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5257-5257
Open Access | Times Cited: 4
The Role of Interleukin 10 in Keloid Therapy
Anastasia Dessy Harsono, Theddeus O.H. Prasetyono, Ismail Hadisoebroto Dilogo
Annals of Plastic Surgery (2021) Vol. 88, Iss. 6, pp. 617-621
Closed Access | Times Cited: 9
Anastasia Dessy Harsono, Theddeus O.H. Prasetyono, Ismail Hadisoebroto Dilogo
Annals of Plastic Surgery (2021) Vol. 88, Iss. 6, pp. 617-621
Closed Access | Times Cited: 9
The coadministration of trehalose dibehenate and monosodium urate crystals promotes an antitumor phenotype in human‐derived myeloid cells
Kristel Kodar, Melanie J. McConnell, Jacquie L. Harper, et al.
Immunology and Cell Biology (2020) Vol. 98, Iss. 5, pp. 411-422
Closed Access | Times Cited: 8
Kristel Kodar, Melanie J. McConnell, Jacquie L. Harper, et al.
Immunology and Cell Biology (2020) Vol. 98, Iss. 5, pp. 411-422
Closed Access | Times Cited: 8
Influence of Galectin-9 Treatment on the Phenotype and Function of NK-92MI Cells in the Presence of Different Serum Supplements
Mátyás Meggyes, Dávid U. Nagy, Tímea Balassa, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1066-1066
Open Access | Times Cited: 8
Mátyás Meggyes, Dávid U. Nagy, Tímea Balassa, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1066-1066
Open Access | Times Cited: 8
Impact ofIL-10Promoter Polymorphisms and IL-10 Serum Levels on Advanced Laryngeal Squamous Cell Carcinoma and Survival Rate
Agnė Pašvenskaitė, Rasa Liutkevičienė, Greta Gedvilaitė, et al.
Cancer Genomics & Proteomics (2021) Vol. 18, Iss. 1, pp. 53-65
Open Access | Times Cited: 7
Agnė Pašvenskaitė, Rasa Liutkevičienė, Greta Gedvilaitė, et al.
Cancer Genomics & Proteomics (2021) Vol. 18, Iss. 1, pp. 53-65
Open Access | Times Cited: 7
Immunohistochemical expression of interlukin10 (IL10) and heat shock protein-90 (HSP-90) in prostatic carcinoma
Wasan A. Bakir, Hiba Ahmed Gaidan, Methaq Mueen Al-Kaabi
Indian Journal of Pathology and Microbiology (2020) Vol. 63, Iss. 2, pp. 230-230
Open Access | Times Cited: 5
Wasan A. Bakir, Hiba Ahmed Gaidan, Methaq Mueen Al-Kaabi
Indian Journal of Pathology and Microbiology (2020) Vol. 63, Iss. 2, pp. 230-230
Open Access | Times Cited: 5
Cytokine-regulating activity of anti-virus preparation CelAgripus in Burkitt's lym-phoma stable B-cell lines
A. N. Narovlyansky, М. В. Мезенцева, И. А. Суетина, et al.
Problems of Virology (2019) Vol. 64, Iss. 4, pp. 165-172
Open Access | Times Cited: 3
A. N. Narovlyansky, М. В. Мезенцева, И. А. Суетина, et al.
Problems of Virology (2019) Vol. 64, Iss. 4, pp. 165-172
Open Access | Times Cited: 3
Cucumis sativus (Cucurbitaceae) seed oil prevents benzo(a)pyrene‐induced prostate cancer in vitro and in vivo
Berlise Yengwa Bakam, Judith Christiane Ngo Pambe, Timothy Grey, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 9, pp. 2069-2083
Closed Access | Times Cited: 1
Berlise Yengwa Bakam, Judith Christiane Ngo Pambe, Timothy Grey, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 9, pp. 2069-2083
Closed Access | Times Cited: 1
Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies
Laura Schwenk, Susan Wittig, Bernd Gruhn
Journal of Cancer Research and Clinical Oncology (2021) Vol. 148, Iss. 4, pp. 985-991
Open Access | Times Cited: 3
Laura Schwenk, Susan Wittig, Bernd Gruhn
Journal of Cancer Research and Clinical Oncology (2021) Vol. 148, Iss. 4, pp. 985-991
Open Access | Times Cited: 3
Association of Interleukin-10 -592C/A Polymorphism and Cervical Cancer Risk: a Meta- Analysis
Brehima Diakité, Yaya Kassogué, Mamoudou Maiga, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Brehima Diakité, Yaya Kassogué, Mamoudou Maiga, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
The mechanism of magnesium isoglycyrrhizinate in regulating the inflammatory microenvironment of gastric cancer
Yuqing Miao, Wenli Zhou, K. Wei, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Yuqing Miao, Wenli Zhou, K. Wei, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Association of the Interleukin-10-592C/A Polymorphism and Cervical Cancer Risk: A Meta-Analysis
Brehima Diakité, Yaya Kassogué, Mamoudou Maiga, et al.
Genetics Research (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 1
Brehima Diakité, Yaya Kassogué, Mamoudou Maiga, et al.
Genetics Research (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 1
Expression of CISH, an Inhibitor of NK Cell Function, Increases in Association with Ovarian Cancer Development and Progression
Jasmin C. Acosta, Janice M. Bahr, Sanjib Basu, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 299-299
Open Access
Jasmin C. Acosta, Janice M. Bahr, Sanjib Basu, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 299-299
Open Access
A joint profile of cytokines and immune cell populations may identify HNSCC patients who benefit from nivolumab treatment. The Gruppo Oncologico Nord-Ovest (GONO) study Nivactor T-2
Marco Merlano, Matteo Paccagnella, Nerina Denaro, et al.
Research Square (Research Square) (2023)
Open Access
Marco Merlano, Matteo Paccagnella, Nerina Denaro, et al.
Research Square (Research Square) (2023)
Open Access
Interleukin-10-592 Polymorphism: Impact on Relapse and Survival After Allogeneic Hematopoietic Stem Cell Transplantation in Children With Hematological Malignancies
Laura Schwenk, Susan Wittig, Bernd Gruhn
Research Square (Research Square) (2021)
Open Access
Laura Schwenk, Susan Wittig, Bernd Gruhn
Research Square (Research Square) (2021)
Open Access